FindTrial
Sign In

A study for EGFR testing in lung cancer patients.

Study to evaluate the prevalence of epidermal growth factor receptor(EGFR) mutation status small cell lung cancer (SCLC) in India.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2015/03/005648
Enrollment
150
Registered
2015-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients of Lung Cancer

Interventions

Intervention1: Not Applicable: Not Applicable

Sponsors

Not yet available
Lead Sponsor
Not yet available
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria Patients must meet the following criteria for study entry: • Adult male or female patients of age >= 18years. • Diagnosed case of small cell lung cancer with availability of representative tumor specimen for genetic analysis, from the biopsy sample.

Exclusion criteria

Exclusion criteria: Exclusion Criteria Patients who meet the following criteria will be excluded from study: • Non-availability of biopsy sample and inadequate tissue sample.

Design outcomes

Primary

MeasureTime frame
The primary objective for this study is: Prevalence of EGFR mutations in Small Cell Lung Cancer (SCLC) patients in Indian population Timepoint: 1 year—

Secondary

MeasureTime frame
The secondary objectives for this study are: Prevalence of different types of EGFR mutations in SCLC patients in Indian population Correlation of EGFR mutation status with demography Correlation of EGFR mutation status with clinico-pathological characteristics Timepoint: 1 year—

Countries

India

Contacts

Public ContactDr Anuradha Chougule

Tata Memorial Hospital

anu_c1112@hotmail.com9820431265

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026